SEATTLE, March 22, 2016 /PRNewswire/ -- Blood Cell Storage, Inc. (BCSI) and Concile Diagnostics S.L., a Spanish corporation, announced today an exclusive distribution relationship for the SAFE Sens TrakStation™ / TrakPod™ continuous pH monitoring systems into large format incubators in Spain, Portugal and Italy. Products are available immediately.
"Our entry into the Spanish marketplace is an important step forward since Spain is well respected in human assisted reproductive technology (ART)," said Russ Aldrich, CEO of BCSI. "We are excited to be working with Concile on the launch of the TrakStation and TrakPod as well as supporting Concile with their current SAFE Sens IVM customers," Aldrich said.
"We have been working with Blood Cell Storage, Inc. (BCSI) on both generations of the SAFE Sens continuous pH monitoring products for IVF," said Joan Carles Bueno, managing director of Concile Diagnostics S.L. "We see the need for clinics to have accurate and stable pH measurements for better outcomes of IVF procedures," he added.
TrakStation and TrakPod are the latest generation of continuous pH monitoring laboratory instruments from BCSI. With the capability of monitoring from one (1) to eight (8) chambers simultaneously, the system provides the lab manager or clinician with assurance of a stable incubator environment throughout the five (5) to seven (7) day IVF cycle. Further, the system requires no expensive calibration or adjustments during the process. One disposable sensor lasts the entire cycle and is replaced between cycles; a replaceable QC alignment tool adjusts the instrument to factory specifications in under ten (10) seconds after each cycle is complete.
ABOUT CONCILE DIAGNOSTICS S.L.
Based in Barcelona, Spain, Concile actively contributes to improving the quality of life of people and their welfare through the implementation of diagnostic and fertility methods and products, innovative and cost-efficient household levels, for each of the markets supported, creating value-added for customers and shareholders, that reflects a continuous improvement of prescribed treatments as a result of the products marketed by Concile.
Concile has a direct presence in the following countries: Austria, Bosnia, Spain, Portugal, Switzerland, Italy, Serbia and Montenegro. In other countries Concile works through a wide network of distributors.
Concile prides itself on employees with excellent training and long experience in the field of IVF and in vitro diagnostics and our competent partners that optimally complement our services. Concile also understands the needs and expectations of customers with business-oriented thinking focused on the end user while providing knowledge of medical technology specialized marketing to support our customers. For more information, contact Joan Carles Bueno at email@example.com.
Blood Cell Storage, Inc. (BCSI), based in Seattle, Washington, is an international laboratory instrument and medical devices company. BCSI's patented technology and products benefit patients, clinicians, researchers, pathologists and doctors. In addition to IVF monitors, the company's fluorescent dyes, micro-fluidics, nucleic acid extraction capabilities and automated systems reduce healthcare costs and improve patient outcomes. For more information, contact Russ Aldrich at firstname.lastname@example.org.
Company Contact: Russ Aldrich, CEO, 425-654-8449 (D), 858-775-9240 (C)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blood-cell-storage-inc-and-concile-diagnostics-sl-announce-distribution-relationship-300239878.html
SOURCE Blood Cell Storage, Inc.